Journey Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-3.85	-29.63	-43.99	5.28	3.63
Depreciation & Amortization	3.86	4.37	2.56	0.1	0.09
Share-Based Compensation	2.61	4.43	2.47	0.15	0.24
Other Operating Activities	2.63	7.3	36.79	-0.4	5.06
Operating Cash Flow	5.24	-13.53	-2.18	5.13	9.02
Operating Cash Flow Growth	-	-	-	-43.09%	-
Other Investing Activities	-5	-20	-10	-1.2	-2.4
Investing Cash Flow	-5	-20	-10	-1.2	-2.4
Share Issuance / Repurchase	4.62	0.14	32.54	0.01	0
Debt Issued / Paid	-9.42	16.69	3.06	-0.5	-3.55
Other Financing Activities	-	-0.37	17.42	-	-
Financing Cash Flow	-4.8	16.46	53.02	-0.49	-3.55
Net Cash Flow	-4.56	-17.08	40.84	3.45	3.07
Free Cash Flow	5.24	-13.53	-2.18	5.13	9.02
Free Cash Flow Growth	-	-	-	-43.09%	-
Free Cash Flow Margin	6.62%	-18.37%	-3.45%	11.52%	25.82%
Free Cash Flow Per Share	0.29	-0.77	-0.21	0.56	0.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).